Clinical Trial Update: Cannabidiol (CBD) in Pain Reduction for Knee Osteoarthritis [Phase 2, Phase 3]

View source ↗

Summary

This document notes a cannabidiol (CBD) trial for pain reduction in knee osteoarthritis that is in Phase 2/Phase 3 and currently recruiting, sponsored by NYU La…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• Cannabidiol (CBD) (cannabidiol)

Snippet

Sponsor: NYU Langone Health | Conditions: Knee Arthritis | Phase 2, Phase 3 | Status: RECRUITING